Recurrent Pregnancy Loss in Jaipur: Causes, Diagnosis & Paths to a Successful Pregnancy

Recurrent pregnancy loss is not simply 'bad luck repeated.' It is a distinct clinical syndrome warranting systematic investigation. The American Society for Reproductive Medicine (ASRM) and the Royal College of Obstetricians and Gynaecologists (RCOG) both recommend beginning a formal RPL workup after two consecutive losses, especially when the woman is 35 or older or when each loss has been confirmed by ultrasound or histopathology.

In Jaipur, awareness of this protocol is growing, particularly among the educated, working-age population concentrated in areas like C-Scheme and Vaishali Nagar. However, a significant proportion of couples still present to fertility clinics only after three or four losses, primarily because early losses are dismissed as 'chemical pregnancies' or attributed to stress. This delay can cost precious reproductive years, especially for women over 35 whose ovarian reserve is already declining.

HomeIVF's Jaipur patient intake data consistently shows that a structured RPL workup — initiated after the second loss — dramatically reduces total time to a successful pregnancy compared with an expectant management approach. Early investigation is not over-medicalisation; it is proactive, compassionate care.

Understanding why RPL occurs is the essential first step toward treating it. The causes are genuinely heterogeneous, which is why a multi-disciplinary panel rather than a single test is required.

**Chromosomal and genetic factors** are the leading culprits, contributing to 50–60% of early losses. De novo embryonic aneuploidy (abnormal chromosome number) is most common, but parental balanced translocations — where one partner carries a rearranged chromosome that is harmless to them but lethal to embryos — account for 2–5% of RPL cases and can only be detected through parental karyotyping.

**Uterine anatomical abnormalities** such as a septate uterus, submucous fibroids, intrauterine adhesions (Asherman's syndrome), or a bicornuate uterus together account for 10–15% of RPL. These are particularly relevant in Jaipur, where some patients from Mansarovar and surrounding areas report prior dilatation-and-curettage (D&C) procedures that may have caused intrauterine scarring.

**Thrombophilias**, especially antiphospholipid syndrome (APS), impair placental blood flow and are found in roughly 5–15% of RPL patients. **Hormonal and metabolic disorders** — including poorly controlled thyroid disease, hyperprolactinaemia, and insulin resistance related to PCOS — contribute meaningfully. **Unexplained RPL**, where no identifiable cause is found despite thorough investigation, accounts for up to 40–50% of cases, but even here structured support can achieve good outcomes.

RPL does not always announce itself dramatically. Many losses occur before a heartbeat is visible on ultrasound — these 'biochemical pregnancies' show a rising then falling hCG level and may resemble a late, slightly heavier period. Because they are so early, couples and even primary-care physicians sometimes do not document them systematically, making it harder to identify the true number of losses.

Warning signs that warrant an urgent RPL workup include: two or more documented pregnancy losses at any gestational age; a prior loss associated with a foetal heartbeat (which statistically carries a lower miscarriage risk and therefore raises red flags when it occurs); a personal or family history of blood clots, lupus, or autoimmune disease; irregular menstrual cycles or signs of PCOS; and any prior uterine surgery including D&C, myomectomy, or caesarean section.

Couples in Jaipur — whether based in the older, denser neighbourhoods of C-Scheme or newer localities like Vaishali Nagar — should be aware that emotional symptoms matter too. Anxiety and anticipatory grief during a subsequent pregnancy are nearly universal after RPL and should be addressed alongside physical investigations. HomeIVF's care model integrates counselling referrals as a standard component of every RPL pathway, not an afterthought.

A comprehensive RPL workup is a structured panel, not a single blood test. The HomeIVF Medical Board recommends the following evidence-based investigations for all couples presenting with RPL in Jaipur.

**Parental karyotyping** of both partners identifies balanced chromosomal translocations. This is a once-in-a-lifetime blood test with results typically available in 3–4 weeks. **Uterine assessment** is conducted via 3D transvaginal ultrasound or saline infusion sonohysterography (SIS); hysteroscopy is reserved for cases where intervention is likely required. These services are accessible to patients from Malviya Nagar and surrounding south Jaipur without needing to travel to Delhi or Mumbai.

**Antiphospholipid antibody panel** — including anticardiolipin antibodies (IgG and IgM), anti-β2-glycoprotein-I, and lupus anticoagulant — must be tested twice, 12 weeks apart, for a diagnosis of APS. **Thyroid function tests** (TSH, free T4, TPO antibodies) and a **prolactin level** complete the hormonal screen. Fasting insulin and glucose, along with an AMH to assess ovarian reserve, are added where clinically indicated.

**Preimplantation Genetic Testing for Aneuploidies (PGT-A)** — testing embryos for chromosomal normality before IVF transfer — is available through HomeIVF and is increasingly recommended for RPL couples where chromosomal causes are suspected. The platform's AI-assisted cycle monitoring ensures that stimulation protocols are optimised before egg retrieval, improving the number of euploid (chromosomally normal) embryos available.

Treatment is always cause-directed. There is no universal RPL protocol — which is precisely why a thorough workup matters before any intervention.

For **antiphospholipid syndrome**, low-dose aspirin combined with prophylactic low-molecular-weight heparin (LMWH) through the first trimester significantly improves live birth rates. HomeIVF coordinates with haematologists to ensure dosing and monitoring are correct throughout the pregnancy.

For **uterine anomalies**, hysteroscopic septum resection or adhesiolysis can be curative, with post-operative pregnancy outcomes markedly improved. Submucous fibroids distorting the cavity are best removed before attempting conception.

For **thyroid dysfunction**, optimising levothyroxine dose to keep TSH below 2.5 mIU/L before conception reduces miscarriage risk substantially. HomeIVF's digital monitoring platform allows Jaipur patients to submit thyroid panel results via app and receive dosing guidance within 24 hours — no repeated clinic visits required.

For couples with **unexplained RPL**, evidence supports progesterone supplementation (vaginal micronised progesterone 400 mg twice daily) from a positive pregnancy test through 12 weeks, based on the PRISM trial data. Where IVF with **PGT-A** is chosen, IVF packages starting from ₹1.5 lakh are available through HomeIVF, making chromosomally screened embryo transfers accessible to Jaipur couples without the prohibitive costs associated with premium hospital settings.

**Emotional and psychological support** — including structured pregnancy-of-unknown-viability (PUV) protocols — is integrated into every RPL treatment plan on the HomeIVF platform.

One of the most distressing aspects of RPL management is the repeated need for early-pregnancy monitoring — serial hCG measurements, early viability scans, progesterone checks — all of which traditionally require frequent clinic attendance. For a working professional in Vaishali Nagar or a mother managing family responsibilities in Mansarovar, taking half a day off work every few days for blood draws is both disruptive and emotionally exhausting.

HomeIVF's home-monitoring model addresses this directly. Certified phlebotomists visit the patient's home to collect samples, which are processed at NABL-accredited partner laboratories. Results feed into the HomeIVF digital dashboard, where the assigned senior specialist reviews them and communicates findings through the app, typically within the same business day. Early viability scans are coordinated with partner diagnostic centres across Jaipur, with priority slots reserved for HomeIVF patients.

This model is particularly valuable during the anxiety-laden first trimester following RPL, where fortnightly or even weekly scan reassurance meaningfully reduces psychological distress — a benefit supported by NICE guidance on pregnancy after miscarriage. The continuity of care, with the same clinical team following a patient from pre-conception workup through delivery, is a key differentiator that HomeIVF consistently delivers for Jaipur families.

Despite Jaipur's emergence as a healthcare hub for Rajasthan, RPL care faces several structural challenges that HomeIVF is specifically designed to overcome.

**Fragmentation of care** is the most cited barrier. Couples often see a gynaecologist for the loss, a haematologist for the thrombophilia screen, an endocrinologist for thyroid management, and a fertility specialist for IVF — each in a different part of the city, with no single physician coordinating the bigger picture. HomeIVF's multidisciplinary care model unifies all of these specialists under one digital platform, with a shared care record that every team member can access.

**Stigma and privacy concerns** are acutely relevant in a city like Jaipur, where social networks are tight and reproductive struggles are rarely discussed openly. Many couples from C-Scheme and Malviya Nagar explicitly prefer the discretion of a home-based consultation over sitting in a busy fertility clinic waiting room. HomeIVF's in-home consultations and digital follow-ups provide exactly this level of privacy.

**Limited awareness of evidence-based RPL protocols** means that many couples are still advised to 'just try again' after two losses, without any investigation. HomeIVF's AI-powered intake assessment flags RPL patterns immediately and routes patients to the appropriate workup pathway, ensuring that no couple in Jaipur falls through the diagnostic gap.

While every RPL journey is unique, understanding what recovery can look like gives couples a realistic, hope-anchored framework. Consider the archetype of a 32-year-old woman from Vaishali Nagar who experienced three early losses over 18 months. Her workup through HomeIVF revealed a balanced chromosomal translocation in her partner, an abnormality that had gone undetected because previous care had not included parental karyotyping. The couple proceeded with IVF and PGT-A, generating two euploid blastocysts. The first frozen embryo transfer resulted in an ongoing pregnancy, now past 28 weeks.

Or consider a 38-year-old professional from Malviya Nagar whose RPL was attributable to antiphospholipid syndrome. Commenced on aspirin and LMWH from a positive pregnancy test, with weekly hCG and fortnightly scan monitoring co-ordinated by HomeIVF, she completed her first trimester without loss — the first time in four years of trying.

These archetypes reflect the realistic range of outcomes that systematic RPL care can achieve. The HomeIVF Medical Board's clinical review of RPL cases consistently finds that the single biggest predictor of eventual success is the completeness of the initial workup — not luck, not age alone, but thorough, evidence-based investigation followed by targeted treatment.